EHP exits SCA Pharma

Enhanced Healthcare Partners has exited its investment in SCA Pharmaceuticals as a result of the latter's sale to The Vistria Group and Excellere Capital Management.

To view this content, you need to sign in.

You should only be asked to sign in once. Not the case? Click here

Register now to access this content and more for free.

Share this